Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Williams

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Human Immunology|May 20, 2008
Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairsT M Williams, T Winden, M Setterholm, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Journal of the American Chemical Society|July 18, 2001
Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferaseC J Dinsmore, M J Bogusky, J C Culberson, et al.
Bone Marrow Transplantation|March 21, 2000
The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairsC K Hurley, L A Baxter-Lowe, A B Begovich, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferaseC J Dinsmore, J M Bergman, D D Wei, et al.
Journal of Medicinal Chemistry|March 29, 1996
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferaseT M Williams, T M Ciccarone, S C MacTough, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.
Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Human Immunology|May 20, 2008
Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairsT M Williams, T Winden, M Setterholm, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Journal of the American Chemical Society|July 18, 2001
Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferaseC J Dinsmore, M J Bogusky, J C Culberson, et al.
Bone Marrow Transplantation|March 21, 2000
The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairsC K Hurley, L A Baxter-Lowe, A B Begovich, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferaseC J Dinsmore, J M Bergman, D D Wei, et al.
Journal of Medicinal Chemistry|March 29, 1996
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferaseT M Williams, T M Ciccarone, S C MacTough, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.
Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.
Pageof 17